Alterations in the neural circuits from peripheral afferents to the spinal cord: possible implications for diabetic polyneuropathy in streptozotocin-induced type 1 diabetic rats

Diabetic polyneuropathy (DPN) presents as a wide variety of sensorimotor symptoms and affects approximately 50% of diabetic patients. Changes in the neural circuits may occur in the early stages in diabetes and are implicated in the development of DPN. Therefore, we aimed to detect changes in the expression of isolectin B4 (IB4, the marker for nonpeptidergic unmyelinated fibers and their cell bodies) and calcitonin gene-related peptide (CGRP, the marker for peptidergic fibers and their cell bodies) in the dorsal root ganglion (DRG) and spinal cord of streptozotocin (STZ)-induced type 1 diabetic rats showing alterations in sensory and motor function. We also used cholera toxin B subunit (CTB) to show the morphological changes of the myelinated fibers and motor neurons. STZ-induced diabetic rats exhibited hyperglycemia, decreased body weight gain, mechanical allodynia and impaired locomotor activity. In the DRG and spinal dorsal horn, IB4-labeled structures decreased, but both CGRP immunostaining and CTB labeling increased from day 14 to day 28 in diabetic rats. In spinal ventral horn, CTB labeling decreased in motor neurons in diabetic rats. Treatment with intrathecal injection of insulin at the early stages of DPN could alleviate mechanical allodynia and impaired locomotor activity in diabetic rats. The results suggest that the alterations of the neural circuits between spinal nerve and spinal cord via the DRG and ventral root might be involved in DPN.

[1]  Zhen-Zhen Kou,et al.  Noise-induced hearing loss is correlated with alterations in the expression of GABAB receptors and PKC gamma in the murine cochlear nucleus complex , 2013, Front. Neuroanat..

[2]  Sheng-Xi Wu,et al.  Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes. , 2013, Pain physician.

[3]  Z. Tabka,et al.  Intense exercise training is not effective to restore the endothelial NO-dependent relaxation in STZ-diabetic rat aorta , 2013, Cardiovascular Diabetology.

[4]  Quan-xin Feng,et al.  Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn , 2012, BMC Gastroenterology.

[5]  John H. Martin,et al.  Selective Corticospinal Tract Injury in the Rat Induces Primary Afferent Fiber Sprouting in the Spinal Cord and Hyperreflexia , 2012, The Journal of Neuroscience.

[6]  S. McMahon,et al.  Understanding chronic inflammatory and neuropathic pain , 2012, Annals of the New York Academy of Sciences.

[7]  K. Meijer,et al.  Lower extremity muscle strength is reduced in people with type 2 diabetes, with and without polyneuropathy, and is associated with impaired mobility and reduced quality of life. , 2012, Diabetes research and clinical practice.

[8]  H. Andersen.  Motor dysfunction in diabetes , 2012, Diabetes/metabolism research and reviews.

[9]  W. Wang,et al.  RU486 (mifepristone) ameliorates cognitive dysfunction and reverses the down-regulation of astrocytic N-myc downstream-regulated gene 2 in streptozotocin-induced type-1 diabetic rats , 2011, Neuroscience.

[10]  Yun-qing Li,et al.  Ketamine Depresses Toll-Like Receptor 3 Signaling in Spinal Microglia in a Rat Model of Neuropathic Pain , 2011, Neurosignals.

[11]  P. Delmas,et al.  Molecular mechanisms of mechanotransduction in mammalian sensory neurons , 2011, Nature Reviews Neuroscience.

[12]  A. Todd,et al.  Neuronal circuitry for pain processing in the dorsal horn , 2010, Nature Reviews Neuroscience.

[13]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[14]  S. Waxman,et al.  Neuropathic pain in diabetes—evidence for a central mechanism , 2010, Nature Reviews Neurology.

[15]  Andrew Burgess,et al.  Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance , 2010, Proceedings of the National Academy of Sciences.

[16]  Ralf Baron,et al.  A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms , 2009, PAIN.

[17]  J. Galligan,et al.  Transient receptor potential vanilloid subtype 1 channel mediated neuropeptide secretion and depressor effects: role of endoplasmic reticulum associated Ca2+ release receptors in rat dorsal root ganglion neurons , 2008, Journal of hypertension.

[18]  M. Pauza,et al.  Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity , 2008, Molecular pain.

[19]  C. Woolf,et al.  The neuropathic pain triad: neurons, immune cells and glia , 2007, Nature Neuroscience.

[20]  Douglas W. Zochodne,et al.  Does diabetes mellitus target motor neurons? , 2007, Neurobiology of Disease.

[21]  H. E. Torebjörk,et al.  Abnormal Function of C-Fibers in Patients with Diabetic Neuropathy , 2006, The Journal of Neuroscience.

[22]  J. Eggermont,et al.  Effects of Noise-Induced Hearing Loss at Young Age on Voice Onset Time and Gap-in-Noise Representations in Adult Cat Primary Auditory Cortex , 2006, Journal of the Association for Research in Otolaryngology.

[23]  W. Willis,et al.  Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP , 2006, Molecular pain.

[24]  Karen L Price,et al.  Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. , 2005, Clinical therapeutics.

[25]  Dan Ziegler,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[26]  A. Verkhratsky,et al.  Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons , 2005, Molecular and Cellular Neuroscience.

[27]  D. Zochodne,et al.  Direct insulin signaling of neurons reverses diabetic neuropathy. , 2004, Diabetes.

[28]  A. Todd,et al.  Do central terminals of intact myelinated primary afferents sprout into the superficial dorsal horn of rat spinal cord after injury to a neighboring peripheral nerve? , 2004, The Journal of comparative neurology.

[29]  M. Gold,et al.  Voltage-gated sodium channels and hyperalgesia. , 2004, Annual review of pharmacology and toxicology.

[30]  M. Vasko,et al.  Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C , 2003, Pain.

[31]  W. Willis,et al.  The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin , 2003, Pain.

[32]  M. Haneda,et al.  Diabetic neuropathy and nerve regeneration , 2003, Progress in Neurobiology.

[33]  D. Wright,et al.  Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice , 2003, Experimental Neurology.

[34]  I. Wilkinson,et al.  Spinal-cord involvement in diabetic peripheral neuropathy , 2001, The Lancet.

[35]  W. Schady,et al.  Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology , 2001, Acta Neuropathologica.

[36]  D. Wright,et al.  GDNF Rescues Nonpeptidergic Unmyelinated Primary Afferents in Streptozotocin-Treated Diabetic Mice , 2001, Experimental Neurology.

[37]  Christian Broberger,et al.  Neuropeptides — an overview , 2000, Neuropharmacology.

[38]  P. Wall,et al.  Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury , 2000, Pain.

[39]  T. Larson,et al.  Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. , 2000, Diabetes care.

[40]  G. Michael,et al.  Differential Expression of the mRNA for the Vanilloid Receptor Subtype 1 in Cells of the Adult Rat Dorsal Root and Nodose Ganglia and Its Downregulation by Axotomy , 1999, The Journal of Neuroscience.

[41]  S. McMahon,et al.  A Distinct Subgroup of Small DRG Cells Express GDNF Receptor Components and GDNF Is Protective for These Neurons after Nerve Injury , 1998, The Journal of Neuroscience.

[42]  I. Nadelhaft,et al.  Increased levels of nerve growth factor in the urinary bladder and hypertrophy of dorsal root ganglion neurons in the diabetic rat , 1998, Brain Research.

[43]  H. Andersen,et al.  Disordered Mobility of Large Joints in Association with Neuropathy in Patients with Long‐standing Insulin‐dependent Diabetes Mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[44]  P. Dyck,et al.  Pathologic Alterations in the Diabetic Neuropathies of Humans: A Review , 1996, Journal of neuropathology and experimental neurology.

[45]  C. Woolf,et al.  Somatic pain--pathogenesis and prevention. , 1995, British journal of anaesthesia.

[46]  S. Kuwajima,et al.  Immunochemical Detection of Advanced Glycation End Products in Renal Cortex From STZ-Induced Diabetic Rat , 1993, Diabetes.

[47]  P. Fernyhough,et al.  Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones , 1993, Brain Research.

[48]  W. J. Litchy,et al.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.

[49]  C. Stevens,et al.  Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.

[50]  J. Polak,et al.  An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene product 9.5 in man and commonly employed laboratory animals. , 1991, The American journal of anatomy.

[51]  J. Roberts,et al.  Stabilization of tubulin mRNAs by insulin and insulin-like growth factor I during neurite formation. , 1989, Brain research. Molecular brain research.

[52]  P. Dyck,et al.  Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy , 1986, Annals of neurology.

[53]  I. Duce,et al.  An ultrastructural classification of the neuronal cell bodies of the rat dorsal root ganglion using zinc iodide-osmium impregnation , 1977, Cell and Tissue Research.

[54]  J. Polak,et al.  Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats , 2004, Histochemistry.

[55]  J. Dunlap,et al.  Slowing of Motor Nerve Conduction Velocity in Streptozotocin-induced Diabetic Rats is Preceded by Impaired Vasodilation in Arterioles that Overlie the Sciatic Nerve , 2000, International journal of experimental diabetes research.

[56]  T. Hökfelt,et al.  Increased uptake and transport of cholera toxin B-subunit in dorsal root ganglion neurons after peripheral axotomy: possible implications for sensory sprouting. , 1999, The Journal of comparative neurology.

[57]  G. Grant,et al.  Early decline and late restoration of spinal cord binding and transganglionic transport of isolectin B4 from Griffonia simplicifolia I after peripheral nerve transection or crush. , 1996, Restorative neurology and neuroscience.

[58]  P. Fernyhough,et al.  Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. , 1994, Brain research. Molecular brain research.